Literature DB >> 11207255

Cell surface-expressed moesin-like receptor regulates T cell interactions with tissue components and binds an adhesion-modulating IL-2 peptide generated by elastase.

A Ariel1, R Hershkoviz, I Altbaum-Weiss, S Ganor, O Lider.   

Abstract

The adhesion of leukocytes to the extracellular matrix (ECM) depends on their responses to variations in the chemotactic signals in their milieu, as well as on the functioning of cytoskeletal and context-specific receptors. Ezrin, radixin, and moesin constitute a family of proteins that link the plasma membrane to the actin cytoskeleton. The surface expression of moesin on T cells and its role in cell adhesion has not been fully elucidated. Recently, we found that IL-2 peptides generated by elastase modified the adhesion of activated T cells to ECM ligands. Here, we further examined the adhesion regulatory effects of EFLNRWIT, one of the IL-2 peptides, as well as the existence and putative function of its receptor on T cells. We found that when presented to T cells in the absence of another activator, the EFLNRWIT peptide induced cell adhesion to vessel wall and ECM components. Binding of a radiolabeled peptide to T cells, precipitation with the immobilized peptide, and amino acid sequencing of the precipitated protein revealed that EFLNRWIT exerts its function via a cell surface-expressed moesin-like moiety, whose constitutive expression on T cells was increased after activation. This notion was further supported by our findings that: 1) anti-moesin mAb inhibited the binding of T cells to the immobilized EFLNRWIT peptide, 2) immobilized recombinant moesin bound the IL-2 peptide, and 3) soluble moesin inhibited the EFLNRWIT-induced T cell adhesion to fibronectin. Interestingly, moesin appears to be generally involved in T cell responses to adhesion-regulating signals. Thus, the IL-2 peptide EFLNRWIT appears to exert its modulating capacities via an adhesion-regulating moesin-like receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207255     DOI: 10.4049/jimmunol.166.5.3052

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Characterization of a novel intracellular heparanase that has a FERM domain.

Authors:  Karen J Bame; Indumati Venkatesan; Jean Dehdashti; Jeffrey McFarlane; Rebecca Burfeind
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

2.  Moesin-induced signaling in response to lipopolysaccharide in macrophages.

Authors:  K H Zawawi; A Kantarci; U Schulze-Späte; T Fujita; E L Batista; S Amar; T E Van Dyke
Journal:  J Periodontal Res       Date:  2010-06-10       Impact factor: 4.419

3.  Role for moesin in lipopolysaccharide-stimulated signal transduction.

Authors:  Iveta Iontcheva; Salomon Amar; Khalid H Zawawi; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

4.  Amaranthus leucocarpus lectin recognizes a moesin-like O-glycoprotein and costimulates murine CD3-activated CD4(+) T cells.

Authors:  Maria Arenas-Del Ángel; Martha Legorreta-Herrera; Guillermo Mendoza-Hernández; Yonathan Garfias; Raul Chávez; Edgar Zenteno; Ricardo Lascurain
Journal:  Immun Inflamm Dis       Date:  2015-06-05

5.  Moesin Is a Novel Biomarker of Endothelial Injury in Sepsis.

Authors:  Yikun Chen; Jiajia Wang; Lei Zhang; Jianjie Zhu; Yuanyuan Zeng; Jian-An Huang
Journal:  J Immunol Res       Date:  2021-02-13       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.